Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Study completedNCT04257617
What this trial is testing

A Trial of ZL-1201 in Subjects With Advanced Cancer

Who this might be right for
Advanced Cancer
Zai Lab (Shanghai) Co., Ltd. 37
Not applicableStudy completedNCT06168825
What this trial is testing

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

Who this might be right for
CancerBreast CancerBrain Cancer+13 more
Inova Health Care Services 40
Not applicableLooking for participantsNCT07285668
What this trial is testing

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Wisconsin, Madison 38
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Not applicableNot Yet RecruitingNCT07703644
What this trial is testing

Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients

Who this might be right for
Hematologic NeoplasmsGram-Negative Bacterial InfectionsPseudomonas Aeruginosa Infection+2 more
Sizhou Feng 60
Early research (Phase 1)Study completedNCT00602693
What this trial is testing

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Masonic Cancer Center, University of Minnesota 41
Not applicableUnknownNCT05632874
What this trial is testing

The Effect of Relaxing Breathing Exercise Applied to Patients Before Bone Marrow Biopsy on Vital Signs, Pain and Anxiety Levels

Who this might be right for
Bone Marrow Cancer
Uskudar University 72
Testing effectiveness (Phase 2)Study completedNCT02125318
What this trial is testing

Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Who this might be right for
ThrombocytosisMyeloproliferative Neoplasms
Galena Biopharma, Inc. 18
Not applicableEnded earlyNCT03943082
What this trial is testing

Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

Who this might be right for
Malignant NeoplasmHematopoietic and Lymphoid Cell Neoplasm
University of California, San Francisco 252
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Not applicableWithdrawnNCT04412135
What this trial is testing

The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

Who this might be right for
Hematologic Cancer
University Hospital, Limoges
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07563010
What this trial is testing

Menin-Inhibitor Targeted Maintenance in AML

Who this might be right for
Relapsed Adult AMLStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
Center for International Blood and Marrow Transplant Research 146
Early research (Phase 1)Ended earlyNCT05338346
What this trial is testing

ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorsHematological Malignancies
Antengene Discovery Limited 22
Testing effectiveness (Phase 2)Study completedNCT00750815
What this trial is testing

Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 58
Testing effectiveness (Phase 2)Study completedNCT01050621
What this trial is testing

Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective

Who this might be right for
Cancer
Jewish General Hospital 14
Not applicableUnknownNCT05692713
What this trial is testing

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

Who this might be right for
Chronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more
University of British Columbia 320
Early research (Phase 1)Study completedNCT01627275
What this trial is testing

Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Mitchell Horwitz, MD 28
Next Page